Alvogen is a multinational pharmaceuticals company focused on complex generic products.
Alvogen is committed to building a next-generation generics company through the strategic selection of products, partners and markets, and the utilization of a consolidated global supply chain. The company has more than 200 pharmaceutical products in development and registration with over 80 products to be launched in 2011.
Our product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology. Alvogen has access to first-class regulatory, development and manufacturing capabilities in Asia, Europe and North-America.
The Alvogen brand is the result of a clear strategy. We are not afraid to follow an unbeaten path in our effort to differentiate Alvogen in the dynamic marketplace. Our symbol is a bold variation of the letter A, underlining our commitment to excel through collaboration and unity. The color code is unique in our field. A vibrant and joyful yellow conveys a feeling of creativity and clarity. More
Alvogen has business activities in over 20 countries and is constantly looking for growth opportunities and collaborations. The company has access to first-class regulatory, development and manufacturing capabilities in Asia, Europe and North-America.
Alvogen is building a new leader in generic pharmaceuticals. Through strategic selection of markets, products and partners, the company is well positioned for future growth.
View brochure
© 2010 Alvogen. All right reserved